PCN140 IMPACT OF TUMOR RESPONSE ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH VELCADE/MELPHALAN/PREDNISONE (V-MP)- RESULTS FROM THE VISTA TRIAL
Abstract
Authors
J Meunier A Regnault D Robinson K Rosa JF San Miguel H van de Velde PG Richardson A Cakana R Dhawan